Results 31 to 40 of about 2,238 (168)

Therapeutic effect of 0.1% Tacrolimus Eye Ointment in Allergic Ocular Diseases [PDF]

Journal of Clinical and Diagnostic Research, 2016
Introduction: Allergic Ocular Diseases (AODs) like Atopic Keratoconjunctivitis (AKC) and Vernal Keratoconjunctivitis (VKC) are chronic forms of ocular allergy that can cause severe visual complications. Pathogenesis of AODs is uncertain and treatment
RAKESH K BAROT, SATISH C SHITOLE, NUPUR BHAGAT, DEEPAK PATIL, PAWAN SAWANT, KALPITA PATIL   +5 more
doaj   +1 more source

A Case of Refractory Vernal Keratoconjunctivitis Showing Improvement after the Administration of Upadacitinib for the Treatment of Atopic Dermatitis

Diagnostics
Vernal keratoconjunctivitis is a persistent allergic ocular disease predominantly mediated by the T-helper 2 lymphocyte-associated immune response. The standard therapeutic approaches for vernal keratoconjunctivitis include topical corticosteroids and ...
Yoshihito Mima, Eri Tsutsumi, Tsutomu Ohtsuka, Ippei Ebato, Yukihiro Nakata, Taro Kubota, Yuta Norimatsu   +6 more
doaj   +1 more source

Long-term outcomes of 0.1% tacrolimus eye drops in eyes with severe allergic conjunctival diseases

Allergy, Asthma & Clinical Immunology, 2021
Background Because atopic dermatitis does not heal completely, associated severe atopic keratoconjunctivitis (AKC) and vernal keratoconjunctivitis (VKC) often require long-term treatment.
Hiroyuki Yazu, Kazumi Fukagawa, Eisuke Shimizu, Yasunori Sato, Hiroshi Fujishima   +4 more
doaj   +1 more source

Diagnostic criteria of chronic conjunctivitis: atopic keratoconjunctivitis and vernal keratoconjunctivitis

Current Opinion in Allergy & Clinical Immunology, 2023
Purpose of review Chronic ocular allergies, vernal (VKC) and atopic keratoconjunctivitis (AKC) are relatively rare conditions that require definite diagnostic criteria to the most appropriate therapeutical approach. Recent findings The diagnosis of both VKC and AKC is generally ...
Leonardi, Andrea, Righetti, Giuseppe, Giovannini, Giulia, De Marchi, Vittorio, Occhiuto, Matteo   +4 more
openaire   +3 more sources

Japanese Guideline for Allergic Conjunctival Diseases

Allergology International, 2011
The definition, classification, pathogenesis, test methods, clinical findings, criteria for diagnosis, and therapies of allergic conjunctival disease are summarized based on the Guidelines for Clinical Management of Allergic Conjunctival Disease (Second ...
Etsuko Takamura, Eiichi Uchio, Nobuyuki Ebihara, Shigeaki Ohno, Yuichi Ohashi, Shigeki Okamoto, Naoki Kumagai, Yoshiyuki Satake, Jun Shoji, Yayoi Nakagawa, Kenichi Namba, Kazumi Fukagawa, Atsuki Fukushima, Hiroshi Fujishima   +13 more
doaj   +1 more source

Positive regulation of innate immune response by miRNA-let-7a-5p

Frontiers in Genetics, 2023
Background: We have hypothesized that different factors are involved in the severity of ACD and AD because some but not all patients with atopic dermatitis (AD) present with allergic conjunctival disease (ACD) including severe types such as atopic ...
Mayumi Ueta, Hiromi Nishigaki, Seitaro Komai, Katsura Mizushima, Risa Tamagawa-Mineoka, Yuji Naito, Norito Katoh, Chie Sotozono, Shigeru Kinoshita   +8 more
doaj   +1 more source

Dupilumab's Real‐World Efficacy and Safety Across Age Groups for Children and Adolescents With Paediatric Atopic Dermatitis

Australasian Journal of Dermatology, Volume 67, Issue 5, Page 301-308, August 2026.
ABSTRACT Background/Objectives Dupilumab is an anti‐interleukin (IL)‐4 receptor (IL‐4Rα) monoclonal antibody used to manage atopic dermatitis (AD). There is a paucity of real‐world Australian data for dupilumab in paediatric AD, especially regarding differences in clinical profiles between age groups.
Paul Sun Woo Kim, Jacqueline Tu, Kelvin Truong, Gloria Fong, William Luu, Peter Barclay, Melanie Wong, Li‐Chuen Wong   +7 more
wiley   +1 more source

Japanese guidelines for allergic conjunctival diseases 2017

Allergology International, 2017
The definition, classification, pathogenesis, test methods, clinical findings, criteria for diagnosis, and therapies of allergic conjunctival disease are summarized based on the Guidelines for Clinical Management of Allergic Conjunctival Disease (Second ...
Etsuko Takamura, Eiichi Uchio, Nobuyuki Ebihara, Shigeaki Ohno, Yuichi Ohashi, Shigeki Okamoto, Naoki Kumagai, Yoshiyuki Satake, Jun Shoji, Yayoi Nakagawa, Kenichi Namba, Kazumi Fukagawa, Atsuki Fukushima, Hiroshi Fujishima   +13 more
doaj   +1 more source

Ocular Manifestations in Dogs With Facial Nerve Dysfunction

Veterinary Ophthalmology, Volume 29, Issue 4, July 2026.
ABSTRACT Objective To characterize the spectrum and frequency of ocular abnormalities associated with facial nerve dysfunction (FND) in dogs and to assess clinical outcomes, with specific comparison between brachycephalic (BC) and non‐brachycephalic (NBC) breeds: Methods Medical records of dogs with FND evaluated between 2009 and 2023 at the ...
L. Gaztelu, M. Leiva, T. Peña, J. Ríos
wiley   +1 more source

Reproxalap ‐ A Novel Treatment Option for Allergic Conjunctivitis – A Comprehensive Narrative Review

Health Science Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Background and Aims Allergic conjunctivitis is a prevalent, immune‐mediated hypersensitivity disorder of the ocular surface affecting 10%–20% of the global population. Current therapeutic options, while effective to some extent, are often limited by side effects and inconsistent efficacy.
Sanila Mughal, Roshanay Ejaz Awan, Hur Abbas, Zahra Sania, Ashna Habib, Syeda Kaneez Sakina, Amina Mahmud, Mohammed Mahmmoud Fadelallah Eljack   +7 more
wiley   +1 more source